► Customized research for NBY vs. OTSKF!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for NBY vs. OTSKF.
↗ Join Our Free Email Newsletter.
► NovaBay Pharmaceuticals, Inc. vs. Otsuka Holdings Co., Ltd.
Industry Match! Industry of Both NBY and OTSKF:
Health Care/Life Sciences
NBY
Data Last Updated: More than 3 wks ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 14.258M
P/E: N/A
P/S: 1.14
Q P/B: 8.54
Y Rev: 12.51M
Q Rev: 1.79M
Beta: N/A

NBY Share Stats
► Outstanding Shares
20.82M
► Float Shares
15.00M
► Percent of Float Short
1.54%
NBY Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
NBY Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share NBY Insights
NBY Profile
► CEO
Mr. Justin M. Hall
► Exchange
NYSE American
► Employees
70.00
► About
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville,...

NBY Financials
Annual Financials
Income Statement
► Revenue
12.51M
► Net Income
(6.55M)
Cash Flow Statement
► Change in Cash / Investments
(15,000)
Balance Sheet
► Cash / Investments
3.18M
► Short Term Debt
None
► Long Term Debt
None
► Total Current Assets
8.61M
► Total Current Liabilities
3.85M
► Total Assets
9.36M
► Total Liabilities
4.41M
► Stockholder Equity
4.95M
Quarterly Financials
Income Statement
► Q Revenue
1.79M
► Q Net Income
(2.53M)
Cash Flow Statement
► Q Change in Cash / Investments
736,000
Balance Sheet
► Q Cash / Investments
3.67M
► Q Short Term Debt
1.07M
► Q Long Term Debt
2.76M
► Q Total Current Assets
7.5M
► Q Total Current Liabilities
3.35M
► Q Total Assets
9.87M
► Q Total Liabilities
8.2M
► Q Stockholder Equity
1.67M

NBY Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

OTSKF
Data Last Updated: 3 days ago
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: 24.259B
P/E: 21.79
P/S: 18805.43
Q P/B: 14022.54
Y Rev: 1.29T
Q Rev: 357.63B
Beta: 0.49

OTSKF Share Stats
► Outstanding Shares
N/A
► Float Shares
377.49M
► Percent of Float Short
N/A
OTSKF Insider Stats
► Percent Outstanding Insider Ownership
0%
► Percent Outstanding Institution Ownership
20.39%
OTSKF Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share OTSKF Insights
OTSKF Profile
► CEO
Mr. Ichiro Otsuka
► Exchange
OTC
► Employees
32,935
► About
Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures...

OTSKF Financials
Annual Financials
Income Statement
► Revenue
1.29T
► Net Income
85.4B
Cash Flow Statement
► Change in Cash / Investments
(51.59B)
Balance Sheet
► Cash / Investments
285.02B
► Short Term Debt
24.37B
► Long Term Debt
139.97B
► Total Current Assets
933.1B
► Total Current Liabilities
427.5B
► Total Assets
2.48T
► Total Liabilities
744.37B
► Stockholder Equity
1.7T
Quarterly Financials
Income Statement
► Q Revenue
357.63B
► Q Net Income
44.7B
Cash Flow Statement
► Q Change in Cash / Investments
17.94B
Balance Sheet
► Q Cash / Investments
393.14B
► Q Short Term Debt
62.55B
► Q Long Term Debt
198.59B
► Q Total Current Assets
1.03T
► Q Total Current Liabilities
443.65B
► Q Total Assets
2.61T
► Q Total Liabilities
855.26B
► Q Stockholder Equity
1.73T

OTSKF Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

